Living-donor kidney transplant: guidelines with updated evidence

Résumé fourni par la source

n e f r o l o g i a. 2 0 2 3;4 2(S 2):1-4Table 1 -New contributions in living-donor kidney transplant. Ethics, information and coordinationAutonomy and altruism, keys to accepting the living donor.Informed consent more precise and signed in the absence of the recipient.Management of new technologies to disclose information about the LDKT. Living donor evaluationGlomerular filtration rate quantification with exogenous markers.Individual assessment in cases of albuminuria greater than 100 mg/day (ratio 100 mg/g).Optimisation of the detection of communicable diseases (infections, neoplasms). Risk assessmentEstimation of the risk of CKD at 15 years in potential donors (without donation).Metabolic assessment and risk factors for CKD and CVD.Lifetime annual medical check-ups for all donors.A,B,C) and class II (DP, DQ, DR) typing and HLA donor-specific antibodies.Crossmatching (virtual and with T and B lymphocytes).Triple immunosuppression except between identical twins. Compatibility and immunosuppression HLA class I ( Donation and LDKT surgical techniquesKidneys with arterial anomalies or tumours, valid in certain circumstances after bench surgery.Renal artery ligation should not be performed with a hem-o-lok clip system.Robotic surgery as an option in selected cases.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.